Skip to content
OpenCapital
Get started

Maravai LifeSciences Holdings, Inc. MRVI Price / book

Price / book at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.5×-0.3×
Danaher logo
DanaherDHR
2.5×-0.4×
Repligen logo
RepligenRGEN
3.2×-0.4×
ADMA Biologics logo
ADMA BiologicsADMA
5.5×-7.1×
Revvity logo
RevvityRVTY
1.4×-0.3×
TEC
Bio-TechneTECH
3.9×-0.7×

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+186%
Enterprise value$954.59M+182%
P/S4.2×+2.9×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

market cap/total stockholders equity=2×

Based on the most recent quarter.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s price / book?
Maravai LifeSciences Holdings, Inc. (MRVI) reported price / book of 2× in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s price / book changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s price / book increased by 85.4% year-over-year, from 1.1× to 2×.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s price / book?
Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s price / book has grown at a -48.0% compound annual growth rate (CAGR), from 58.3× to 2.2×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.